Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SR-604 by Equilibra Bioscience for Hemophilia A (Factor VIII Deficiency): Likelihood of Approval
SR-604 is under clinical development by Equilibra Bioscience and currently in Phase I for Hemophilia A (Factor VIII Deficiency). According...
Data Insights
SR-604 by Equilibra Bioscience for Hemophilia B (Factor IX Deficiency): Likelihood of Approval
SR-604 is under clinical development by Equilibra Bioscience and currently in Phase I for Hemophilia B (Factor IX Deficiency). According...